Telephone: 312-926-4272; FAX: 312-695-9194;
Comparative effectiveness of donation after cardiac death versus donation after brain death liver transplantation: Recognizing who can benefit†
Version of Record online: 29 MAY 2012
Copyright © 2012 American Association for the Study of Liver Diseases
Volume 18, Issue 6, pages 630–640, June 2012
How to Cite
Jay, C. L., Skaro, A. I., Ladner, D. P., Wang, E., Lyuksemburg, V., Chang, Y., Xu, H., Talakokkla, S., Parikh, N., Holl, J. L., Hazen, G. B. and Abecassis, M. M. (2012), Comparative effectiveness of donation after cardiac death versus donation after brain death liver transplantation: Recognizing who can benefit. Liver Transpl, 18: 630–640. doi: 10.1002/lt.23418
Research for this study was performed in part while the lead author was a National Research Service Award postdoctoral fellow with the Division of Organ Transplantation at the Feinberg School of Medicine under an institutional award from the National Institute of Diabetes and Digestive and Kidney Diseases (grant 5 T32 DK077662-02; the principal investigator was Michael M. Abecassis).
- Issue online: 29 MAY 2012
- Version of Record online: 29 MAY 2012
- Manuscript Accepted: 2 FEB 2012
- Manuscript Received: 8 SEP 2011
- 12007 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1997-2006.http://www.srtr.org/annual_reports/2010/ar_archives. htm. Accessed February 2012.
- 2Deaths: final data for 2006. Natl Vital Stat Rep 2009; 57: 1–134., , , , , .
- 5Centers for Medicare & Medicaid Services. Medicare and Medicaid programs; conditions for coverage for organ procurement organizations (OPOs). Final rule. Fed Regist 2006; 71: 30981–31054.
- 21for Adult-to-Adult Living Donor Liver Transplantation Cohort Study Group. Addition of adult-to-adult living donation to liver transplant programs improves survival but at an increased cost. Liver Transpl 2009; 15: 148–162., , , , , , et al.;
- 28A randomized, prospective, pharmacoeconomic trial of neoral 2-hour postdose concentration monitoring versus tacrolimus trough concentration monitoring in de novo liver transplant recipients. Liver Transpl 2008; 14: 173–180., , , , , , .
- 34Cholestatic liver diseases and health-related quality of life. Am J Gastroenterol 2000; 95: 497–502., , , , .Direct Link:
- 39Clinical Outcomes and Quality of Life in Recipients of Livers Donated after Cardiac Death. Hepatology 2011; 54: 168., , , , , , et al.
- 40Institute of Medicine. Initial National Priorities for Comparative Effectiveness Research. Washington, DC: National Academies Press; 2009.
- 48Scientific Registry of Transplant Recipients. Program and OPO specific reports. http://www.srtr.org/csr/archives/defaultOPO.aspx. Published October 2009. Accessed February 2012.
- 51The graft failure from hepatitis C virus recurrence—does graft type matter? Hepatology 2011; 52: 396., , , , , , et al.
- 52The impact of donation after cardiac death livers on hepatitis C virus recurrence following liver transplantation. Hepatology 2011; 52: 321., , , , , , et al.
- 57UNOS/OPTN (2008). Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1998-2007. Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, Rockville, MD; United Network for Organ Sharing, Richmond, VA.